STALICLA

Curated by Signal

Manufacturer of precision medicinea for neurodevelopmental disorders

Overview

Manufacturer of precision medicinea for neurodevelopmental disorders. The company uses DEPI technology platform to develop pipeline candidate STP7 a multifaceted mGluR5 NAM pipeline to for cocaine abuse and other neurological indications.

Key facts

Founded: 2017
Headquarters: Geneva, Switzerland
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

6 products and services: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

NeuroPro
Developer of device for monitoring brain signals
Life Sciences TechnologyZurich, Switzerland
TOLREMO therapeutics
Developing anti-cancer small molecules targeting novel drug resistance pathways
Life Sciences TechnologyZurich, Switzerland
Mybacs
Manufacturer of probiotic products for digestion
Life Sciences TechnologyBaar, Switzerland

About STALICLA

What does STALICLA do?

Manufacturer of precision medicinea for neurodevelopmental disorders.

Where is STALICLA headquartered?

STALICLA is headquartered in Geneva, Switzerland.

When was STALICLA founded?

STALICLA was founded in 2017.

Which sector is STALICLA in?

STALICLA operates in Life Sciences Technology.

Who are STALICLA's competitors?

Companies similar to STALICLA include NeuroPro, TOLREMO therapeutics, and Mybacs.